ACHV - Company ID 0000949858
ACHIEVE LIFE SCIENCES, INC. trades as ACHV. This page tracks ACHIEVE LIFE SCIENCES, INC. through 999 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
With latest filings
Next research step
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
| Filing | Type | Filed |
|---|---|---|
| EFFECT | - | 2026-05-21 |
| Insider trade | 4 | 2026-05-13 |
| New insider ownership | 3 | 2026-05-13 |
| Employee stock plan | S-8 | 2026-05-12 |
| Securities registration | S-3 | 2026-05-12 |
| Quarterly report | 10-Q | 2026-05-12 |
| Major company event | 8-K | 2026-05-12 |
| Annual report (amended) | 10-K/A | 2026-04-30 |
The largest companies sharing ACHIEVE LIFE SCIENCES, INC.'s SEC industry classification (in vitro & in vivo diagnostic substances).
In its latest fiscal year ACHIEVE LIFE SCIENCES, INC. reported a net loss of $54.65M.